Pro Medicus (PMCUF) Stock Price, News & Analysis

Company Overview

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency. Pro Medicus also provides complementary modules for artificial intelligence integration, data analytics, and teleradiology, supporting both on-premises and cloud-based deployment models.

Founded in 1983 and headquartered in Melbourne, Pro Medicus has expanded its footprint to serve hospitals, imaging centers, and academic medical institutions across Australia, Europe, and North America. Key installations include major health systems and specialist clinics that rely on Pro Medicus solutions to manage high-volume imaging workloads and to collaborate seamlessly across multidisciplinary care teams.

Over its history, Pro Medicus has built a reputation for rapid image delivery and scalable architecture, earning partnerships with leading medical research centers and device vendors. The company is led by an experienced executive team with deep expertise in medical imaging, software engineering, and healthcare operations, driving its mission to improve patient outcomes through innovative information technology.

Key Stats

• Today's Range: $118.20 to $118.20
• 50-Day Range: $108.25 to $147.87
• 52-Week Range: $74.52 to $210.25
• Volume: 15 shs
• Average Volume: 616 shs
• Market Capitalization: $12.35 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $155.00
• Consensus Rating: Hold

Company Calendar

• Today: 8/17/2026
• Next Earnings (Estimated): 8/18/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: OTCMKTS:PMCUF
• CIK: 2013003
• Web: www.promed.com.au
• Phone: 61 3 9429 8800
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Pro Medicus: $155.00
• High Price Target: $155.00
• Low Price Target: $155.00
• Potential Upside/Downside: +31.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 104,460,000
• Free Float: N/A
• Market Cap: $12.35 billion
• Optionable: Not Optionable
• Beta: N/A